THC.CSE
THCBF - OTC
TFHD.F
The website thckiss.buzz will be updated to add the
THC KISS cannabis edibles, are infused with 10 mg of THC KISS extract, a fast acting, full-spectrum, proprietary cannabis extract, invented by
All products are developed, grown, produced, infused and shipped from our state-of-the-art and fully integrated facility located in beautiful
About THC
THC BioMed is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is on the leading edge of scientific research and the development of products and services in the medical and recreational cannabis industry. Management believes THC BioMed is well-positioned to be in the forefront of this rapidly growing industry.
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC BioMed. Forward-looking information is based on certain key expectations and assumptions made by the management of THC BioMed. In some cases, you can identify forward-looking statements using words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements in this release are made as of the date of this press release and include that a list of the
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/thc-biomed-receives-purchase-orders-from-30-dispensaries-in-the-province-of-manitoba-301383743.html
SOURCE
© Canada Newswire, source